Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
Denise EvansTembeka SinekeKathryn SchnippelRebecca BerhanuCaroline GovathsonAndrew BlackLawrence LongSydney RosenPublished in: BMC health services research (2018)
Pre-treatment mortality reduced significantly during late Xpert MTB/RIF coverage but there was no significant difference after treatment was initiated. Despite improvements there is still a significant diagnosis and treatment gap for patients diagnosed with RR-TB and improving treatment outcomes remains critical.
Keyphrases
- pulmonary tuberculosis
- drug resistant
- mycobacterium tuberculosis
- south africa
- multidrug resistant
- healthcare
- end stage renal disease
- palliative care
- affordable care act
- acinetobacter baumannii
- ejection fraction
- newly diagnosed
- quality improvement
- chronic kidney disease
- prognostic factors
- pain management
- type diabetes
- dna methylation
- gene expression
- pseudomonas aeruginosa
- emergency department
- risk factors
- hiv aids
- cystic fibrosis
- hiv testing
- cardiovascular disease
- men who have sex with men